½ÃÀ庸°í¼
»óÇ°ÄÚµå
1363832
¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø, ±â¼úº°, ±â°üº°, Áö¿ªº° ºÐ¼®(2023-2030³â)Global Perfusion Systems Market Size study & Forecast, by Technology (Normothermic Machine Perfusion, Hypothermic Machine Perfusion) by Organ ( Heart, Lung, Kidney, Liver, Others) and Regional Analysis, 2023-2030 |
°ü·ù ½Ã½ºÅÛÀº ÀÇ·á ¹× °úÇÐ ºÐ¾ß¿¡¼ Á¶Á÷°ú Àå±â¿¡ »ê¼Ò¿Í ¿µ¾çÀÌ Ç³ºÎÇÑ ¾×ü¸¦ Áö¼ÓÀûÀ¸·Î °ø±ÞÇϱâ À§ÇØ »ç¿ëµÇ´Â ÀåÄ¡ ¹× ±â¼úÀÔ´Ï´Ù.
ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ü³»ÀÇ ÀÚ¿¬ÀûÀÎ Ç÷¾× ¼øȯÀ» ¸ð¹æÇϵµ·Ï ¼³°èµÇ¾î ü¿Ü¿¡¼ Á¶Á÷À» º¸Á¸Çϰųª ¿¬±¸ÇÒ ¼ö ÀÖ´Â ÅëÁ¦µÈ ȯ°æÀ» Á¦°øÇÕ´Ï´Ù. °ü·ù ½Ã½ºÅÛÀº Àå±â À̽Ŀ¡¼ ÀÌ½Ä Àü Àå±â¸¦ º¸Á¸ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. °ü·ù ½Ã½ºÅÛÀº »ê¼Ò¿Í ¿µ¾çºÐÀ» °ø±ÞÇÏ°í, ³ëÆó¹°À» Á¦°ÅÇÏ°í, ¿Âµµ¿Í ¾Ð·ÂÀ» Á¶ÀýÇÏ¿© Àå±âÀÇ »ýÁ¸ ´É·Â°ú ±â´ÉÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. °ü·ù ½Ã½ºÅÛ ½ÃÀåÀº Àå±â ÀÌ½Ä »ç·Ê Áõ°¡, ½ÉÇ÷°ü ¹× È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù.
½ÉÀå À̽Ä, °£ À̽Ä, ½ÅÀå À̽Ä, Æó À̽İú °°Àº Àå±â À̽Ŀ¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °í±Þ °ü·ù ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ Å©°Ô Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. °ü·ù ½Ã½ºÅÛÀº ±âÁõÀÚÀÇ Àå±â¸¦ ü¿Ü¿¡¼ º¸Á¸ÇÏ°í Æò°¡ÇÏ¿© ÀÌ½Ä ¼º°ø·üÀ» ³ôÀÌ°í »ç¿ë °¡´ÉÇÑ Àå±â Ç®À» È®ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. 2022³â 3¿ù ¹Ì±¹ º¸°ÇÀÚ¿ø¼ºñ½º±¹ÀÌ ¹ßÇ¥ÇÑ Á¤º¸¿¡ µû¸£¸é 2021³â ¹Ì±¹¿¡¼ ¾à 4¸¸ °ÇÀÇ Àå±â À̽ÄÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. ¶ÇÇÑ 2021³â¿¡ ¹Ì±¹¿¡¼ ÁøÇàµÈ Àå±â À̽ÄÀº »ýü ÀÌ½Ä 9,236°Ç, ½ÅÀå ÀÌ½Ä 2¸¸ 6,670°ÇÀ̾ú½À´Ï´Ù. ¶ÇÇÑ ±¹Á¦½ÅÀåÇÐȸ(ISN)¿Í ±¹Á¦½ÅÀåÀç´Ü¿¬¸Í(IFKF)ÀÌ 2021³â¿¡ ¹ßÇ¥ÇÑ ¼öÄ¡¿¡ µû¸£¸é, ½ÅÀ庴Àº ¼¼°èÀûÀ¸·Î ¾à 8¾ï 5,000¸¸ ¸íÀÌ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ, ¼¼°è Àα¸ 10¸í Áß 1¸íÀÌ ¸¸¼º½ÅÀ庴(CKD)À» ¾Î°í ÀÖÀ¸¸ç, ¼¼°è ¸¸¼º½ÅÀ庴ÀÇ ºÎ´ãÀº Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ¿©, ¿À´Â 2040³â¿¡´Â ¸¸¼º½ÅÀ庴ÀÌ ¼¼°è 5À§ »ç¸Á¿øÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÈ´Ù°í ¹àÇû½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¸¸¼º ½ÅÀå ÁúȯÀÇ ºóµµ¿Í ÇÔ²² ½ÅÀå À̽ÄÀÇ Çʿ伺ÀÌ Áõ°¡ÇÏ¿© ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÌ½Ä ±â¼úÀÇ ¹ßÀü°ú Àå±â ±âÁõÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎ ¹× ´Ù¾çÇÑ ´ÜüÀÇ À̴ϼÅƼºê°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç°ú ´ëü Ä¡·á¹ýÀÇ °¡¿ë¼ºÀº 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ ¿ìÀ§, ´Ù¾çÇÑ ¸¸¼º Áúȯ ¹× ½ÉÇ÷°ü Áúȯ Áõ°¡, Àå±â ÀÌ½Ä »ç·Ê Áõ°¡, ÀÌ Áö¿ªÀÇ ±â¼ú ¹ßÀüÀ» À§ÇÑ À̴ϼÅƼºê Áõ°¡·Î ÀÎÇØ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÉÇ÷°ü ¹× È£Èí±â Áúȯ°ú °°Àº Áúº´ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª¿¡¼´Â Àå±â À̽İú °ü·ÃµÈ Á¤ºÎÀÇ ¿ìÈ£Àû ÀÎ »óȯ Á¤Ã¥°ú ÀÇ·á ÁöÃâ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ°í ÀÖ½À´Ï´Ù.
ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆľÇÇÏ°í ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.
Perfusion systems are devices or techniques used in medical and scientific fields to deliver a continuous flow of oxygenated and nutrient-rich fluid to tissues or organs. These systems are designed to mimic the natural blood circulation in the body and provide a controlled environment for preserving or studying tissues outside of the body. Perfusion systems are utilized in organ transplantation to preserve organs before transplantation. They help to maintain the viability and function of organs by delivering oxygen and nutrients, removing waste products, and controlling temperature and pressure. The Perfusion Systems market is expanding because of factors such as rising cases of organ transplant and increase in the prevalence of cardiovascular and respiratory diseases.
The growing demand for organ transplants, including heart, liver, kidney, and lung transplants, has significantly increased the need for advanced perfusion systems. Perfusion systems play a crucial role in preserving and assessing donor organs outside the body, improving the success rates of transplants and expanding the pool of available organs. According to information released by the Health Resources and Services Administration in March 2022, around 40,000 organ transplants were carried out in the United States in 2021. Also carried out in the United States in 2021 were 9,236 live transplants and 26,670 kidney transplants. Furthermore, according to figures published in 2021 by the International Society of Nephrology (ISN) and International Federation of renal Foundations (IFKF), renal disease afflicted almost 850.0 million individuals globally. The same source also stated that one in ten people globally have chronic kidney disease (CKD). By 2040, it is anticipated that CKD would rank as the fifth most prevalent cause of death globally because of its steadily rising global burden. As a result, the need for kidney transplants is anticipated to rise along with the frequency of chronic renal disease, fueling market expansion. In addition, advancement in transplantation techniques and rising initiatives by government and various organizations to promote organ donations is creating a lucrative opportunity to the market. However, the stringent regulatory requirements and availability of alternative treatment method stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Perfusion Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the dominance of key market players, rising prevelance of various chronic and cardiovascular diseases, rising organ transplant cases, and rising initiatives for technological advancement in the region. Whereas, Asia Pacific region is projected to have fastest growth owing to factors such as rising prevelance of diseases such as cardiovascular and respiratory diseases. In the region, favorable government reimbursement polices related to organ transplantation, and increasing healthcare expenditure is supporting the market growth.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.